F₁·F_o ATP Synthase/ATPase: Contemporary View on Unidirectional Catalysis

Area of Science:

• Biochemistry
• Molecular Biology
• Microbiology

Background:

• F1·Fo-ATP synthases/ATPases (F1·Fo) are vital molecular machines coupling proton gradients to ATP synthesis or hydrolysis.
• Increasing drug resistance necessitates new antimicrobial targets, with F1·Fo enzymes emerging as promising candidates, especially for anti-tuberculosis therapies.

Purpose of the Study:

• To review the current understanding of "unidirectional" F1·Fo catalysis in bacteria, particularly mycobacteria.
• To elucidate the complex regulatory mechanisms of F1·Fo in bacteria that influence its catalytic directionality.
• To provide insights for developing strategies to discover new drugs targeting bacterial energy production.

Main Methods:

• Literature review focusing on F1·Fo-ATP synthase/ATPase mechanisms.
• Analysis of bacterial and mycobacterial F1·Fo enzyme regulation and catalysis.
• Exploration of existing research on F1·Fo inhibitors for antimicrobial applications.

Main Results:

• Bacterial F1·Fo enzymes, especially in mycobacteria, exhibit "unidirectional" catalysis, primarily synthesizing ATP without significant hydrolysis.
• This unidirectional nature presents a complex regulatory challenge for drug development.
• Understanding this specific catalytic mechanism is crucial for selective drug targeting.

Conclusions:

• The "unidirectional" catalysis of F1·Fo in bacteria offers a unique target for antimicrobial drug development.
• Targeting bacterial energy production via F1·Fo inhibition holds promise for combating drug-resistant strains, including tuberculosis.
• Further research into the regulation of bacterial F1·Fo is essential for designing effective and selective inhibitors.